Tissue expression biomarkers in breast cancer, such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are extensively used as tumor-specific markers to guide breast cancer therapy. This evidence concerns the gene ERBB2 and neoplasm.